ALVOW Alvotech Warrant
$0.32▲ +0.00%
Unknown
Other
Volume 203
Avg Volume (10D) –
Key Metrics & Fundamentals
Market Cap
–
P/E Ratio
–
Div Yield
–%
52W Range
0.30 - 0.32
% vs 50 MA
0.17%
% vs 200 MA
–%
RSI-14
51.5
MACD Histogram
+0.0200
Beta (1Y vs SPY)
-0.84
Free Cash Flow
-$64.56M
Gross Rev
$105.77M
Gross Profit
$53.58M
EBITDA
-$40.14M
COGS
$52.20M
Operating Exp
$65.28M
Operating Income
-$11.71M
EBIT
-$11.71M
Pretax Income
-$66.76M
Net Income
-$66.82M
Price & Volume History
Loading chart…
Recent News
Update: Alvotech Shares Rise After FDA Accepts Biologics License Application for AVT80
MT Newswires · Aug 31, 2026 6:47 PM
Alvotech Says FDA Accepted Biologics License Application for AVT80
MT Newswires · Aug 31, 2026 9:31 AM
Alvotech Announces FDA Acceptance for Review of Biologics License Application for AVT80, Expanding Proposed Biosimilar Program for Entyvio® to Subcutaneous Presentations
GlobeNewswire · Aug 31, 2026 8:30 AM
Has Alvotech (NasdaqGM:ALVO) Fallen Below Fair Value After Its Deal?
Simply Wall St. · Aug 29, 2026 10:09 PM
Why Alvotech (ALVO) Is Up 11.7% After Expanding Biosimilar Deal With Lotus Pharmaceutical
Simply Wall St. · Aug 29, 2026 11:07 AM
Alvotech to present at upcoming investor conferences in September
GlobeNewswire · Aug 27, 2026 12:00 PM
Alvotech (ALVO) Gets New ‘Buy’ Reco. Should Investors Follow?
Insider Monkey · Aug 24, 2026 11:53 PM
Financial Overview - Income Statement
Quarterly
Jun 2026
See ALVOW's money flow as a full page
Social Sentiment
Avg +0.50 · 1 posts
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.